Vivace Therapeutics Announces Issuance of New U.S. Composition of Matter Patents

SAN MATEO, Calif.: SAN MATEO, Calif., Feb. 3, 2022 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, today announced that the United States Patent and Trademark Office (USPTO) has issued the company two new composition of matter patents. The...

Click to view original post